Clinical Trial Update: NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating NaF PET/CT imaging to assess treatment response to TAK-700 in castration-resistant prostate cancer with bone metastases; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• TAK-700 (Orteronel)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Prostatic Neoplasms, Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-07-19